NATURECELL CO.,LTD. Logo

NATURECELL CO.,LTD.

Biotech company developing stem cell therapies, food, beverages, and cosmetics.

007390 | KO

Overview

Corporate Details

ISIN(s):
KR7007390008
LEI:
Country:
South Korea
Address:
서울특별시 영등포구 국회대로76길 10 5층, 서울특별시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

NATURECELL CO.,LTD. is a South Korean biotechnology company with diversified operations across three primary segments: stem cell research, food and beverages, and cosmetics. The company's high-tech bio division focuses on the research and development of stem cell-based therapies for degenerative diseases. In the consumer goods sector, Naturecell manufactures and sells a range of products including canned goods, fruit juices, and health-functional foods. It also develops and markets cosmetics, often leveraging its biotechnological expertise.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-16 00:00
Report Publication Announcement
[기재정정]기업설명회(IR)개최
Korean 10.7 KB
2025-09-08 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.0 KB
2025-09-08 00:00
Pre-Annual General Meeting Information
주주총회소집결의 (임시주주총회)
Korean 9.0 KB
2025-08-21 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.3 KB
2025-08-19 00:00
Legal Proceedings Report
[기재정정]기타주요경영사항 (조인트스템 판매계약 유지 결정)
Korean 12.6 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.8 MB
2025-08-06 00:00
Regulatory News Service
[기재정정]기타주요경영사항 (조인트스템 국내 품목허가 결과 통지)
Korean 12.9 KB
2025-05-20 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 156.0 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.6 MB
2025-05-09 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-03-31 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 25.0 KB
2025-03-26 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 29.1 KB
2025-03-26 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 155.2 KB
2025-03-26 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등거래계획보고서
Korean 47.5 KB
2025-03-19 00:00
Audit Report / Information
감사보고서제출
Korean 25.3 KB

Automate Your Workflow. Get a real-time feed of all NATURECELL CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NATURECELL CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NATURECELL CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

MATCHING SERVICE JAPAN CO.,LTD. Logo
Specialized recruitment firm connecting legal, finance, and accounting experts with top companies.
Japan
6539
Material Group inc. Logo
A professional services firm offering PR consulting, marketing, and brand strategy.
Japan
156A
Medesis Pharma S.A. Logo
Develops therapies for CNS disorders and radiation exposure via a drug delivery platform.
France
ALMDP
Medicofarma Biotech Spolka Akcyjna Logo
A biotech R&D company developing innovative drugs and devices with a focus on oncology therapies.
Poland
MDB
Medpace Holdings, Inc. Logo
Global CRO providing full-service clinical development to biotech, pharma & medical device industries.
United States of America
MEDP
Develops biomarker-based precision therapies for oncology and other incurable diseases.
South Korea
235980
Medrx Co.,Ltd. Logo
Develops and licenses transdermal drug delivery systems for the pharmaceutical industry.
Japan
4586
Developing nanomedicines and drug delivery systems for oncology, hematology, and diagnostics.
Malaysia
N/A
A holding company driving regional growth by supporting construction, HR, and nursing care businesses.
Japan
7369
Mendus Logo
Developing immunotherapies using dendritic cells to prevent cancer recurrence and improve survival.
Sweden
IMMU

Talk to a Data Expert

Have a question? We'll get back to you promptly.